Revcovi 1.6 mg/mL
elapegademase-lvlr · INJECTION · Chiesi USA, Inc.
Revcovi is an injectable medication given as an intramuscular injection used to treat adenosine deaminase (ADA) deficiency, a rare genetic disorder affecting the immune system. It works by replacing the missing or defective enzyme that the body cannot produce on its own.
Key Facts
- Brand Name
- Revcovi
- Generic Name
- elapegademase-lvlr
- NDC Code (Product)
10122-502- Manufacturer
- Chiesi USA, Inc.
- Strength
- 1.6 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA761092
- Marketing Start
- 10/05/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Revcovi used for?
Revcovi is an injectable medication given as an intramuscular injection used to treat adenosine deaminase (ADA) deficiency, a rare genetic disorder affecting the immune system. It works by replacing the missing or defective enzyme that the body cannot produce on its own.
Is Revcovi a controlled substance?
Revcovi is not classified as a controlled substance by the DEA.
What is the generic name for Revcovi?
The generic name for Revcovi is elapegademase-lvlr. There are no other listed brand versions of elapegademase-lvlr.
What is the NDC code for Revcovi 1.6 mg/mL?
The NDC (National Drug Code) for Revcovi 1.6 mg/mL is 10122-502, listed by Chiesi USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)